Atomo Diagnostics Limited (AT1) Earnings Call Transcripts

35 earnings calls from March 2020 to July 24, 2026

ASX AU Health Care Health Care Equipment and Supplies

Atomo Diagnostics Limited's Latest Earnings Call - Q1 FY2026

In Q1 2026, Aroundtown SA reported net rental income of EUR 297 million, slightly above the EUR 295 million from Q1 2025, driven by a 3% like-for-like rental growth. Adjusted EBITDA remained stable at EUR 250 million, while FFO I decreased by 8% to EUR 70 million, attributed to higher finance expenses. Notably, management raised its FFO I guidance for the fiscal year 2026 to a range of EUR 275 million to EUR 305 million, reflecting the positive impact of increased ownership in Grand City Properties (GCP). The share buyback program is nearing completion, further enhancing per share metrics and signaling strong capital management.

Reported metrics

MetricValueContext
Net Rental Income EUR 297 million (beat) vs EUR 295 million in Q1 2025, +0.7% YoY
Adjusted EBITDA EUR 250 million (inline) inline with Q1 2025
FFO I EUR 70 million (miss) vs EUR 76 million in Q1 2025, -8% YoY
FFO I Guidance EUR 275 million to EUR 305 million (positive) raised from previous guidance
EPRA NTA per Share EUR 8 (positive) up 3% from EUR 7.8 as of December 2025
Liquidity EUR 4.1 billion (positive) plus EUR 1 billion undrawn credit lines

Guidance from management

Management raised its 2026 FFO I guidance to EUR 275 million to EUR 305 million, reflecting the positive impact of the increased stake in GCP and ongoing operational growth. Per share guidance remains unchanged at EUR 0.24 to EUR 0.27.

What management said

This concludes our presentation. As always, you can find further material in our appendix. With that, we would like to start the Q&A. Before we invite your direct telephone questions, we would like to answer questions that we have received by e-mail prior to this call. For simplicity reasons, the team have taken liberty to group similar questions in order to answer as many questions as possible. Allow me now to read...
— Unknown Executive, Q1 FY2026 earnings call
Year-to-date, including after the reporting date, we have signed disposals amounting to circa EUR 300 million, representing around half of our properties held for sale. After the reporting period, we completed disposals in the amount of circa EUR 270 million, primarily consisting of the company's Pentabranded hotels, which includes 11 hotels in Germany, Belgium and France. These hotel properties were previously class...
— Kamaldeep Manaktala, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the sluggish recovery of the German office market and potential impacts on tenant demand. There were also questions about the sustainability of rental growth amidst macroeconomic uncertainties and the effectiveness of the conversion strategy in the current environment.

Main topics on the call

Read the full Atomo Diagnostics Limited transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Atomo Diagnostics Limited

Atomo Diagnostics Limited (AT1) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on ASX and is based in AU. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 35 calls on record spanning March 26, 2020 to July 24, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 35 Atomo Diagnostics Limited earnings call transcripts on record, spanning March 26, 2020 to July 24, 2026. Based on this history, Atomo Diagnostics Limited reports quarterly. The most recent call on file is dated July 24, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
AT1
Exchange
ASX
Country
AU
Sector
Health Care
Industry
Health Care Equipment and Supplies
Calls on record
35
First call
March 26, 2020
Most recent
July 24, 2026
Reporting cadence
quarterly
Quarter Date
Q4 FY2026 Jul 24, 2026 Read transcript
Q1 FY2026 May 27, 2026 Read transcript
Q3 FY2026 Apr 28, 2026 Read transcript
Earnings Calls Mar 4, 2026 Read transcript
Earnings Calls Feb 26, 2026 Read transcript
Q3 FY2025 Nov 26, 2025 Read transcript
Q1 FY2026 Oct 29, 2025 Read transcript
Earnings Calls Sep 2, 2025 Read transcript
Earnings Calls Aug 27, 2025 Read transcript
Q3 FY2025 Apr 30, 2025 Read transcript
Earnings Calls Mar 26, 2025 Read transcript
Earnings Calls Mar 3, 2025 Read transcript
Q2 FY2025 Jan 30, 2025 Read transcript
Q3 FY2024 Nov 27, 2024 Read transcript
Shareholder/Analyst Calls Nov 14, 2024 Read transcript
Q1 FY2025 Oct 29, 2024 Read transcript
Earnings Calls Sep 2, 2024 Read transcript
Q4 FY2024 Jul 25, 2024 Read transcript
Q3 FY2024 Apr 30, 2024 Read transcript
Earnings Calls Mar 27, 2024 Read transcript
Earnings Calls Feb 26, 2024 Read transcript
Q2 FY2024 Jan 30, 2024 Read transcript
Q3 FY2023 Nov 29, 2023 Read transcript
Shareholder/Analyst Calls Nov 1, 2023 Read transcript
Q1 FY2024 Oct 26, 2023 Read transcript
Earnings Calls Aug 30, 2023 Read transcript
Earnings Calls Aug 24, 2023 Read transcript
Q4 FY2023 Jul 26, 2023 Read transcript
Special Calls May 1, 2023 Read transcript
Earnings Calls Mar 29, 2023 Read transcript
Earnings Calls Aug 25, 2022 Read transcript
Earnings Calls Mar 29, 2022 Read transcript
Q3 FY2020 Nov 25, 2020 Read transcript
Earnings Calls Aug 26, 2020 Read transcript
Q4 FY2019 Mar 26, 2020 Read transcript